CompoAtlas

NSP19

Food supplement declared in France, declaration No 2020-7-338, decision dated 6 July 2020

NSP19 is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
NEURALIA SAS
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules
Directions for use
2 gélules par jour tous les matin avec un vere d'eau
Intended populations
Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an)
Objectives stated by the manufacturer (these are not authorised claims)
Mémoire, Ménopause

Declaration 314429, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Dioscorea villosa L.RhizomeExtrait sec hydroalcoolique460 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
MéthylcobalamineVitamine B12pas d'effet indésirable définidose annulée par le Conseil d'État en 2011

Additives

E1204

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2020. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Ce produit est déconseillé aux enfants, aux femmes enceintes ou allaitantes

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line